In contrast, bad prognosis of hepatocellular adenoma was associated with a decrease of FABP1 and increase of hepatocyte nuclear factor 1 α (HNF-1α) and low levels of FABP1 were also found in hepatocarcinoma (HCC) patients (Amiri et al. 2018). This evidence concerns the gene FABP1 and hepatocellular adenoma.